Numerical Model From MIT May Optimize Antibody Drugs
A new study in Nature Biotechnology claims their numerical models and lab experiments have confirmed they can improve a class of drugs based on antibodies by predicting structural changes that will improve its effectiveness.
They've already used the model to create a new version of cetuximab, a drug commonly used to treat colorectal cancer, that binds to its target with 10 times greater affinity than the original molecule.
“New and better methods for improving antibody development represent critical technologies for medicine and biotechnology,” says MIT Professor Dane Wittrup.
Antibodies,…